Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma.

Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma.
复制标题

DOI:
10.1038/cddis.2012.182
复制
发表时间:
2012-12-20
影响因子:
9
通讯作者:
--
中科院分区:
生物学1区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

神经胶质瘤表现出失巢抵抗,对邻近脑实质的侵袭增强,尽管使用标准疗法,但最终还是复发。我们对基质金属蛋白酶 2 (MMP-2) 敲低 4910 和 5310 人神经胶质瘤异种移植细胞中失巢凋亡敏感性增加的研究与 p21 激活激酶 4 (PAK4) 抑制有趣地相关,促使我们进一步研究 PAK4 在神经胶质瘤中的作用。在这里,我们报告 PAK4 上调与神经胶质瘤病理分级的增加呈正相关。 siRNA介导的PAK4敲低可升高失巢凋亡,并通过下调MMP-2、αvβ3-整合素和磷酸表皮生长因子受体(磷酸EGFR)来抑制侵袭和迁移。 cDNA-PCR 阵列揭示了 PAK4 敲低细胞中参与细胞增殖和粘附的必需蛋白的转录抑制。最重要的是,谷胱甘肽 S-转移酶下拉测定证明 MMP-2 是一种新的 PAK4 相互作用蛋白,可与 PAK4 激酶结构域结合。 PAK4si处理的细胞中的单独EGFR/ErbB2抑制剂和αvβ3抗体处理表明PAK4对αvβ3/EGFR存活信号的调节。 PAK4 的过表达显着逆转了两种细胞系中 MMP2si 诱导的细胞死亡。 PAK4 和 MMP-2 的同时缺失会导致失巢凋亡介导的细胞死亡,并严重抑制这些细胞的侵袭和迁移特性。 PAK4si 通过抑制肿瘤中 MMP-2、β3-整合素和磷酸化 EGFR 水平来抑制裸鼠体内肿瘤生长。我们的研究结果表明 PAK4 和 MMP-2 之间存在物理关联,并表明 PAK4/MMP-2 双重靶向在神经胶质瘤治疗中的未来治疗潜力。
Gliomas display anoikis resistance, enhanced invasion in to the adjacent brain parenchyma and eventually recur despite using the standard therapies. Our studies on increased anoikis sensitization in matrix metalloproteinase-2 (MMP-2)-knockdown 4910 and 5310 human glioma xenograft cells were interestingly correlated with p21-activated kinase 4 (PAK4) inhibition, prompting us to further investigate the role of PAK4 in glioma. Here, we report the PAK4 upregulation in positive correlation with increasing glioma pathological grades. The siRNA-mediated PAK4 knockdown elevated anoikis, and inhibited invasion and migration by downregulating MMP-2, αvβ3-integrin and phospho-epidermal growth factor receptor (phospho-EGFR). The cDNA-PCR arrays revealed a transcriptional suppression of essential proteins involved in cell proliferation and adhesion in PAK4-knockdown cells. Most importantly, glutathione S-transferase pull-down assays demonstrated the MMP-2 as a new PAK4-interacting protein which binds to PAK4 kinase domain. Individual EGFR/ErbB2 inhibitor and αvβ3 antibody treatments in PAK4si-treated cells indicated the regulation of αvβ3/EGFR survival signaling by PAK4. Overexpression of PAK4 significantly reversed the MMP2si-induced cell death in both cell lines. Codepletion of PAK4 and MMP-2 resulted in robust anoikis-mediated cell death, and severely inhibited invasive and migratory properties in these cells. PAK4si inhibited in vivo tumor growth in nude mice by inhibiting MMP-2, β3-integrin and phospho-EGFR levels in tumors. Our findings indicate a physical association between PAK4 and MMP-2, and suggest the future therapeutic potential of PAK4/MMP-2 dual targeting in glioma treatment.
DOI: 10.1038/onc.2012.546
发表时间: 2013-10-24
期刊: ONCOGENE
影响因子: 8
作者:
Kesanakurti, D.;Chetty, C.;Maddirela, D. Rajasekhar;Gujrati, M.;Rao, J. S.
通讯作者: Rao, J. S.
DOI: 10.1093/emboj/17.22.6527
发表时间: 1998-11-16
期刊: EMBO JOURNAL
影响因子: 11.4
作者:
Abo, A;Qu, J;Minden, A
通讯作者: Minden, A
DOI: 10.1016/s0092-8674(00)81235-0
发表时间: 1996-05-31
期刊: CELL
影响因子: 64.5
作者:
Brooks, PC;Stromblad, S;Cheresh, DA
通讯作者: Cheresh, DA
DOI: 10.1074/jbc.m110.123497
发表时间: 2010-07-30
影响因子: 4.8
作者:
Li,Zhilun;Zhang,Hongquan;Stromblad,Staffan
通讯作者: Stromblad,Staffan
DOI: 10.1371/journal.pone.0019341
发表时间: 2011-05-04
期刊: PloS one
影响因子: 3.7
作者:
Kesanakurti D;Chetty C;Bhoopathi P;Lakka SS;Gorantla B;Tsung AJ;Rao JS
通讯作者: Rao JS